In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
Patients v. Hospitals: Why define markets at all if every market satisfies the SSNIP Test?
Hospital merger cases are won or lost on geographic market definition. The Third Circuit’s recent finding that it is appropriate to define geographic markets...